Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Net Income (2024 - 2025)

Historic Net Income for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$17.2 million.

  • Connect Biopharma Holdings' Net Income fell 3358.19% to -$17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.3 million, marking a year-over-year decrease of 63307.05%. This contributed to the annual value of -$15.6 million for FY2024, which is 7483.66% up from last year.
  • Per Connect Biopharma Holdings' latest filing, its Net Income stood at -$17.2 million for Q3 2025, which was down 3358.19% from -$12.9 million recorded in Q2 2025.
  • Over the past 5 years, Connect Biopharma Holdings' Net Income peaked at $14.8 million during Q2 2024, and registered a low of -$17.2 million during Q3 2025.